InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Papapetropoulos Spyridon, Director. Officer active across 1 company, notably Adamas Pharmaceuticals Inc. Aggregated, 2 filings have been logged. History available since 2 June 2021. The latest transaction was filed on 2 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Spyridon Papapetropoulos is a Board Member at Adamas Pharmaceuticals Inc. He contributes to the company's governance by overseeing operations and participating in strategic decision-making. His experience in the pharmaceutical sector is valuable for Adamas.